The Food and Drug Administration has posted a Class I notice about Becton Dickinson infusion pumps affected by compatibility issues with Cardinal Health Monoject syringes. Cardinal sent an urgent ...

Becton, Dickinson and Company’s BDX, or popularly known as BD, initiated the recall of its infusion pumps last month after customer reports indicated software issues, potentially leading to inaccurate ...

Washington, D.C.--(Newsfile Corp. - December 16, 2024) - The Securities and Exchange Commission today announced settled charges against Becton, Dickinson and Company (BDX), a New Jersey-based medical ...

FDA has assigned a Class I designation to a recall of CareFusion Alaris infusion pumps, originally announced last month. The agency gave the same designation to a recall of frame membranes that Elite ...

Washington, D.C.--(Newsfile Corp. - December 16, 2024) - The Securities and Exchange Commission today announced settled charges against Becton, Dickinson and Company, a New Jersey-based medical device ...

The US Food and Drug Administration (FDA) has notified healthcare providers of a class 1 recall of CareFusion's Alaris PC unit (model 8015) with software version 9.12. The Alaris PC unit is the ...

A new group of recalls for a repair piece installed in some of BD’s Alaris infusion pumps joins more than a dozen others on the long list of serious recalls involving the device in the last decade.

The Qualcomm Life Capsule Datacaptor Terminal Server and the Becton Dickinson Alaris TIVA Syringe Pump allow remote access without authentication. Two previously undocumented, critical vulnerabilities ...

A workstation used to dock an infusion pump widely used in hospitals and medical facilities has critical security flaws that allow it to be remotely hijacked and controlled, according to security ...

A vulnerability found in software used to monitor some of BD’s infusion pumps could potentially give hackers access to personal data stored in the system. BD posted a cybersecurity bulletin about the ...